NCT03434262
SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain Tumors treatment 1 completed NCT03189706
Study of Chemoimmunotherapy for High-Risk Neuroblastoma treatment 0 active_not_recruiting NCT00180947
Study of Vinorelbine and Cyclofosfamide Among Patients With Refractory Tumours or in Relapse treatment 2 unknown_status NCT06172296
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma treatment 3 recruiting NCT06631391
Phase I Study of Umbilical Cord Blood Natural Killer (NK) Cell Therapy for Children With High-risk, R/R Neuroblastoma. treatment 1 not_yet_recruiting NCT06638931
Agnostic Therapy in Rare Solid Tumors No drug interventions treatment 2 recruiting NCT00107289
Iodine I 131 Metaiodobenzylguanidine in Treating Patients with Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma treatment 2 recruiting NCT01005654
Prospective Comprehensive Molecular Analysis of Endocrine Neoplasms No drug interventions Not Available Not Available recruiting NCT01109394
Comprehensive Omics Analysis of Pediatric Solid Tumors and Establishment of a Repository for Related Biological Studies No drug interventions Not Available Not Available recruiting NCT04724369
Open-Label Study of 18F-mFBG for Imaging Neuroblastoma diagnostic 3 completed NCT05429502
Study of Efficacy and Safety of Ribociclib (LEE011) in Combination With Topotecan and Temozolomide (TOTEM) in Pediatric Patients With Relapsed or Refractory Neuroblastoma and Other Solid Tumors treatment 1 / 2 recruiting NCT06233903
18F-mFBG Expression in Neural Crest Tumors and Organs Innervated by the Sympathetic Nervous System diagnostic 2 not_yet_recruiting NCT04936529
A Study of a Vaccine in Combination with Β-glucan and GM-CSF in People with Neuroblastoma treatment 2 recruiting NCT06625190
Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors treatment 1 / 2 not_yet_recruiting NCT06395103
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01) treatment 1 / 2 recruiting NCT04753658
Real World Data Collection Pediatric Neuroblastoma Treated With Lorlatinib Not Available Not Available terminated NCT04851119
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors treatment 1 / 2 recruiting NCT04947501
A Study of N9 Chemotherapy in Children with Neuroblastoma treatment 0 recruiting NCT05135975
A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors treatment 2 recruiting NCT06057948
A Study of a Vaccine in Combination With Beta-glucan in People With Neuroblastoma treatment 2 recruiting NCT06528496
N10: A Study of Reduced Chemotherapy and Monoclonal Antibody (mAb)-Based Therapy in Children With Neuroblastoma treatment 2 recruiting NCT00003203
Carboplatin and Vincristine Plus Radiation Therapy Followed By Adjuvant Chemotherapy in Treating Young Patients With Newly Diagnosed CNS Embryonal Tumors treatment 2 completed NCT00601003
Study of Nifurtimox to Treat Refractory or Relapsed Neuroblastoma or Medulloblastoma treatment 2 completed NCT03033303
A Study of the Effect of Hu3F8/GM-CSF Immunotherapy Plus Isotretinoin in Patients in First Remission of High-Risk Neuroblastoma treatment 2 active_not_recruiting NCT00002803
Combination Chemotherapy or Observation Following Surgery in Treating Infants With Neuroblastoma treatment 2 completed NCT01962103
Study to Find a Safe Dose and Show Early Clinical Activity of Weekly Nab-paclitaxel in Pediatric Patients With Recurrent/ Refractory Solid Tumors treatment 1 / 2 completed NCT00578864
Protracted Etoposide During Induction Therapy for High Risk Neuroblastoma treatment 2 completed NCT00486564
Safety Study of Nifurtimox for Relapsed or Refractory Neuroblastoma treatment 1 completed NCT05302921
Neoadjuvant Dual Checkpoint Inhibition and Cryoablation in Relapsed/Refractory Pediatric Solid Tumors treatment 2 active_not_recruiting NCT02605421
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma treatment 2 recruiting NCT03496402
Biological Characterisation of High Risk CHildhood Cancer in Children, Adolescents and Young Adults (MICCHADO) No drug interventions other Not Available recruiting NCT00293384
Aprepitant, Granisetron, & Dexamethasone in Preventing Nausea & Vomiting in Pts. Receiving Cyclophosphamide Before a Stem Cell Transplant supportive_care Not Available completed NCT00311584
Irinotecan and Temozolomide in Treating Young Patients With Recurrent Neuroblastoma treatment 2 completed NCT00659984
N2007-01: Ultratrace™ Iobenguane I 131 in Patients With Relapsed/Refractory High-Risk Neuroblastoma treatment 2 completed NCT01701479
Long Term Continuous Infusion ch14.18/CHO Plus s.c. Aldesleukin (IL-2) treatment 1 / 2 unknown_status NCT00471679
Ethanol-Lock Treatment in Preventing Central Venous Catheter Infections in Patients With High-Risk Neuroblastoma supportive_care 1 completed NCT00276679
Temozolomide in Treating Young Patients With High-Risk Relapsed or Refractory Neuroblastoma treatment 2 completed NCT01445379
Phase I Study of Ipilimumab (Anti-CTLA-4) in Children and Adolescents With Treatment-Resistant Cancer treatment 1 completed NCT02765243
Anti-GD2 4th Generation CART Cells Targeting Refractory and/or Recurrent Neuroblastoma No drug interventions treatment 1 completed NCT01838187
Expanded Access Protocol Using 131I-MIBG Therapy +/- Vorinostat for Refractory Neuroblastoma, Pheochromocytoma, or Paraganglioma Not Available Not Available no_longer_available NCT01916187
Imetelstat Given Intravenously Alone and With Standard 13-Cis-Retinoic Acid in Children With Neuroblastoma treatment 1 withdrawn NCT00003887
Lymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell Transplantation No drug interventions treatment 2 completed NCT03294954
GD2 Specific CAR and Interleukin-15 Expressing Autologous NKT Cells to Treat Children With Neuroblastoma No drug interventions treatment 1 recruiting NCT00082654
Study of the Emotional Needs of Caregivers of Stem Cell Transplantation Patients No drug interventions Not Available Not Available completed NCT05990751
Multi-modular Chimeric Antigen Receptor Targeting GD2 in Neuroblastoma No drug interventions treatment 1 recruiting NCT01525251
Nurse Case Manager Model on Neuroblastoma Caregiver's Uncertainty No drug interventions Not Available Not Available unknown_status NCT00793351
Reduced Intensity Stem Cell Transplantation in Children With Relapsed Neuroblastoma After Autologous Transplantation No drug interventions treatment 2 completed NCT00093353
N2003-01: Irinotecan, Temozolomide, and Cefixime in Treating Young Patients With Recurrent or Resistant Neuroblastoma treatment 1 completed NCT02909777
Trial of CUDC-907 in Children and Young Adults With Relapsed or Refractory Solid Tumors, CNS Tumors, or Lymphoma treatment 1 active_not_recruiting NCT02075177
Expanded Access Study of Fenretinide Lym-X-Sorb Plus Ketoconazole in Neuroblastoma Not Available Not Available no_longer_available NCT04337177
Flavored, Oral Irinotecan VAL-413 (Orotecan®) Given With Temozolomide for Treatment of Recurrent Pediatric Solid Tumors treatment 1 recruiting NCT04837547
PEACH TRIAL- Precision Medicine and Adoptive Cellular Therapy No drug interventions treatment 1 recruiting NCT01592045
ch14.18 Pharmacokinetic Study in High-risk Neuroblastoma treatment 1 / 2 completed NCT00793845
Tandem High-dose Chemotherapy and Autologous Stem Cell Rescue in Patients With High-risk Neuroblastoma treatment 2 completed NCT00112645
Donor Stem Cell Transplant in Treating Young Patients With Relapsed or Refractory Solid Tumors treatment 1 completed NCT01058798
The Role of Glycosyltransferases in the Oncogenesis of Neuroblastoma No drug interventions Not Available Not Available completed NCT06574698
Adding Of Naxitamb In Induction Therapy For High Risk Neuroblastoma Not Available Not Available recruiting NCT02914405
Phase I Study of 131-I mIBG Followed by Nivolumab & Dinutuximab Beta Antibodies in Children With Relapsed/Refractory Neuroblastoma treatment 1 recruiting NCT01183897
3F8/GM-CSF Immunotherapy Plus 13-Cis-Retinoic Acid for Primary Refractory Neuroblastoma in Bone Marrow No drug interventions treatment 2 completed NCT01943097
Evaluation of 18F-dopa and 123I-MIBG Uptake in the Patients With Neuroblastoma No drug interventions Not Available Not Available unknown_status NCT02164097
ODSH + ICE Chemotherapy in Pediatric Solid Tumors treatment 1 terminated NCT06071897
Induction Chemoimmunotherapy for Patients With High-risk Neuroblastoma No drug interventions treatment 3 recruiting NCT01163383
131-I-MIBG Therapy for Refractory Neuroblastoma, Expanded Access Protocol Not Available Not Available available NCT00946283
Lactobacillus in Preventing Infection in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Myelodysplastic Syndrome No drug interventions supportive_care Not Available terminated NCT02536183
A Phase I Study of Lyso-thermosensitive Liposomal Doxorubicin and MR-HIFU for Pediatric Refractory Solid Tumors treatment 1 terminated NCT00003661
Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer treatment 2 completed NCT00025428
Combination Chemotherapy Before Surgery in Treating Children With Localized Neuroblastoma treatment 3 completed NCT02780128
Next Generation Personalized Neuroblastoma Therapy treatment 1 terminated NCT00040911
Electroacupuncture in Treating Delayed Nausea and Vomiting in Patients Receiving Chemotherapy For Newly Diagnosed Childhood Sarcoma, Neuroblastoma, Nasopharyngeal Cancer, Germ Cell Tumors, or Hodgkin Lymphoma No drug interventions supportive_care Not Available completed NCT00064311
Ravuconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Stem Cell Transplantation supportive_care 1 / 2 completed NCT00109993
Campath-1H + FK506 and Methylprednisolone for GVHD supportive_care 2 completed NCT00024193
Chemotherapy and Surgery Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Neuroblastoma treatment 2 unknown_status NCT01059071
Safety Study for Refractory or Relapsed Neuroblastoma With DFMO Alone and in Combination With Etoposide treatment 1 completed NCT06104488
A Study of Avutometinib for People With Solid Tumor Cancers treatment 1 recruiting NCT04029688
A Study Evaluating the Safety, Tolerability, Pharmacokinetics and Preliminary Activity of Idasanutlin in Combination With Either Chemotherapy or Venetoclax in Treatment of Pediatric and Young Adult Participants With Relapsed/Refractory Acute Leukemias or Solid Tumors treatment 1 / 2 completed NCT02624388
Study of Genistein in Pediatric Oncology Patients (UVA-Gen001) supportive_care 2 terminated NCT03107988
NANT 2015-02: A Phase 1 Study of Lorlatinib (PF-06463922) treatment 1 active_not_recruiting NCT00072488
Whole-Body MRI and Conventional Imaging in Detecting Distant Metastases in Young Patients With Solid Tumors or Lymphoma No drug interventions diagnostic Not Available unknown_status NCT02439788
3RD GENERATION GD2 SPECIFIC CHIMERIC ANTIGEN RECEPTOR TRANSDUCED AUTOLOGOUS NATURAL KILLER T-CELLS FOR NEUROBLASTOMA treatment 1 withdrawn NCT00206388
Zoledronic Acid (ZOMETA) With Cyclophosphamide With Neuroblastoma and Cortical Bone Involvement treatment 1 completed NCT00003107
Interleukin-12 in Treating Patients With Hematologic Cancers or Solid Tumors treatment 1 completed NCT02169609
Safety Study of Dinutuximab Combined With Immunotherapy to Treat Neuroblastoma treatment 2 completed NCT02745756
A Combined Cell Therapy Approach to the Treatment of Neuroblastoma No drug interventions treatment 1 withdrawn NCT02163356
Fenretinide Lym-X-Sorb + Ketoconazole + Vincristine for Recurrent or Resistant Neuroblastoma treatment 1 terminated NCT00002485
Development of Strategies to Increase Enrollment in Clinical Trials for Children With Cancer No drug interventions Not Available Not Available completed NCT04909515
Naxitamab and Granulocyte-Macrophage Colony Stimulating Factor (GMCSF) and Isotretinoin for Consolidation of Patients With High-Risk Neuroblastoma in First Remission. treatment 2 withdrawn NCT00002515
Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Rare Cancer treatment 2 completed NCT04253015
A Post-Authorisation Safety Study Patient Registry of Patients With Neuroblastoma Being Treated With Dinutuximab Beta No drug interventions Not Available Not Available recruiting NCT00003737
Rebeccamycin Analog in Treating Children With Relapsed or Refractory Neuroblastoma treatment 2 completed NCT02035137
131I-MIBG Alone VS. 131I-MIBG With Vincristine and Irinotecan VS131I-MIBG With Vorinostat treatment 2 completed NCT05918432
Determining Patterns In Study Experiences of Neuroblastoma Patients No drug interventions Not Available Not Available not_yet_recruiting NCT02162732
Molecular-Guided Therapy for Childhood Cancer No drug interventions treatment Not Available completed NCT06296732
Abdominal Neuroblastoma Laparoscopic Surgery Risk Factors Stratification No drug interventions Not Available Not Available recruiting NCT00005952
Temozolomide Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Malignant Glioma or Recurrent CNS or Other Solid Tumors treatment 1 / 2 completed NCT01953900
iC9-GD2-CAR-VZV-CTLs/Refractory or Metastatic GD2-positive Sarcoma and Neuroblastoma treatment 1 active_not_recruiting NCT01510600
Studying Biomarkers in Samples From Patients With High-Risk Neuroblastoma No drug interventions Not Available Not Available completed NCT00539500
Autologous Stem Cell Rescue With CD133+ Selected Cells in High-Risk Neuroblastoma treatment 2 / 3 terminated NCT00070200
Induction Chemotherapy Using Cyclophosphamide and Topotecan in Treating Patients Who Are Undergoing Autologous Peripheral Stem Cell Transplantation for Newly Diagnosed or Progressive Neuroblastoma treatment 1 completed NCT00357500
Etoposide, Cyclophosphamide, Thalidomide, Celecoxib, and Fenofibrate in Relapsed or Progressive Cancer treatment 2 completed NCT00036959
ABT-751 in Treating Young Patients With Refractory Solid Tumors treatment 1 completed NCT01583842
124I-Metaiodobenzylguanidine (MIBG) PET/CT Diagnostic Imaging and Dosimetry for Patients With Neuroblastoma: A Pilot Study diagnostic 0 terminated NCT03545542
Investigating the Microbiome and Volatile Organic Compound Profile of Children With Neuroblastoma No drug interventions basic_science Not Available unknown_status NCT04903899
177Lutetium-DOTATATE in Children With Primary Refractory or Relapsed High-risk Neuroblastoma treatment 2 recruiting NCT00808899
Neuroblastoma Protocol 2008: Therapy for Children With Advanced Stage High Risk Neuroblastoma treatment 2 terminated NCT00900406
Collecting and Storing Tissue and DNA Samples From Patients Undergoing a Donor Stem Cell Transplant No drug interventions Not Available Not Available completed NCT02615106
Anti-angiogenetic Therapy With Radiotherapy for Pediatric Neuroblastoma treatment 2 unknown_status NCT02076906
MR-guided High Intensity Focused Ultrasound (HIFU) on Pediatric Solid Tumors No drug interventions treatment 1 active_not_recruiting NCT00025649
Combination Chemotherapy Followed by Surgery and Peripheral Stem Cell or Bone Marrow Transplantation in Treating Infants With Newly Diagnosed Neuroblastoma treatment 2 completed NCT04730349
A Study of Bempegaldesleukin (BEMPEG: NKTR-214) in Combination With Nivolumab in Children, Adolescents and Young Adults With Recurrent or Treatment-resistant Cancer treatment 1 / 2 terminated NCT01373736
123I-MIBG Scintigraphy in Patients Being Evaluated for Neuroendocrine Tumors No drug interventions diagnostic 3 unknown_status NCT01313936
High-Dose 131I-MIBG Therapy Combined With Vincristine and Five Days of Irinotecan for Resistant/Relapsed Neuroblastoma treatment 1 completed NCT02013336
Phase 1 Dose-escalating Study of MM-398 (Irinotecan Sucrosofate Liposome Injection) Plus Intravenous Cyclophosphamide in Recurrent or Refractory Pediatric Solid Tumors treatment 1 unknown_status NCT00007813
Peripheral Stem Cell Transplantation Plus Chemotherapy in Treating Patients With Malignant Solid Tumors treatment 1 completed NCT00790413
Haploidentical Stem Cell Transplantation in Neuroblastoma treatment 0 unknown_status NCT01518413
Dose Escalation Study of Sorafenib and Irinotecan Combination Therapy in Pediatric Patients With Solid Tumors treatment 1 completed NCT00053118
Chemotherapy and Stem Cell Transplantation in Treating Children With Central Nervous System Cancer treatment 1 completed NCT00526318
Combination Chemotherapy Followed by Stem Cell Transplant and Isotretinoin in Treating Young Patients With High-Risk Neuroblastoma treatment Not Available unknown_status NCT04106219
A Study of LY3295668 Erbumine in Participants With Relapsed/Refractory Neuroblastoma treatment 1 active_not_recruiting NCT01121419
The Role of IMP3 Expression in Patients With Neuroblastoma No drug interventions Not Available Not Available completed NCT05781919
Use of Virtual Reality for Surgical Planning in Neuroblastoma No drug interventions treatment Not Available recruiting NCT00030719
Combination Chemotherapy With or Without Filgrastim Before Surgery, High-Dose Chemotherapy, and Radiation Therapy Followed by Isotretinoin With or Without Monoclonal Antibody in Treating Patients With Neuroblastoma treatment 3 unknown_status NCT06450041
NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial treatment 2 not_yet_recruiting NCT02982941
Enoblituzumab (MGA271) in Children With B7-H3-expressing Solid Tumors treatment 1 completed NCT04559217
68Ga-DOTATATE Neuroblastoma Imaging Pilot diagnostic 2 recruiting NCT00002634
Chemotherapy, Radiation Therapy, Immunotherapy, and Bone Marrow Transplantation in Treating Patients With Neuroblastoma treatment 2 completed NCT06275334
Dinutuximab Beta at the HUS and the Toulouse Oncopole No drug interventions Not Available Not Available recruiting NCT00324324
Moxifloxacin in Preventing Bacterial Infections in Patients Who Have Undergone Donor Stem Cell Transplant supportive_care 3 terminated NCT02924324
Local Injection of Pain Medication to Reduce Pain After Bone Marrow Procedures in Pediatric Neuroblastoma Patients treatment Not Available completed NCT03126916
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL) treatment 3 active_not_recruiting NCT01183416
High-Dose 3F8/GM-CSF Immunotherapy Plus 13-Cis-Retinoic Acid for Consolidation of First Remission After Myeloablative Therapy and Autologous Stem-Cell Transplantation treatment 2 completed NCT00743496
A Phase I Trial Of The Humanized Anti-GD2 Antibody In Children And Adolescents With Neuroblastoma, Osteosarcoma, Ewing Sarcoma and Melanoma No drug interventions treatment 1 completed NCT00644696
Study of Irinotecan and Bortezomib in Children With Recurrent/Refractory Neuroblastoma treatment 1 completed NCT00590096
I-123-MIBG for Imaging of Neuroblastoma and Pheochromocytoma No drug interventions Not Available Not Available completed NCT01987596
Study of Fixed vs. Flexible Filgrastim to Accelerate Bone Marrow Recovery After Chemotherapy in Children With Cancer supportive_care 3 terminated NCT01462396
Allogeneic Stem Cell Transplantation for Advanced Neuroblastoma Using MHC Mismatched Related Donors No drug interventions device_feasibility 1 completed NCT05826158
18F-mFBG LAFOV PET/CT Compared to 123I-mIBG Scintigraphy SPECT/CT for Evaluation of Children With Neuroblastoma No drug interventions diagnostic 3 recruiting NCT00072358
Monoclonal Antibody 3F8 and Sargramostim in Treating Patients With Neuroblastoma treatment 2 completed NCT00132158
ZD1839 and Oral Irinotecan in Treating Young Patients With Refractory Solid Tumors treatment 1 completed NCT00089258
Biological Therapy in Treating Patients With Neuroblastoma That Has Not Responded to Previous Treatment treatment 2 completed NCT00001335
New Therapeutic Strategies for Patients With Ewing's Sarcoma Family of Tumors, High Risk Rhabdomyosarcoma, and Neuroblastoma treatment 2 completed NCT01331135
Aflac ST0901 CHOANOME - Sirolimus in Solid Tumors treatment 1 completed NCT00960063
A Study of Robatumumab (SCH 717454, MK-7454) in Combination With Different Treatment Regimens in Pediatric Participants With Advanced Solid Tumors (P05883, MK-7454-006) treatment 1 terminated NCT00048386
Neuroblastoma Vaccine for Treatment of High-Risk Neuroblastoma After Chemotherapy No drug interventions treatment 1 completed NCT05027386
Apatinib Mesylate Combined With IT Regimen for the Treatment of Recurrent or Refractory Pediatric Neuroblastoma treatment 2 recruiting NCT00703222
A Phase I/II Study Of Immunization With Lymphotactin And Interleukin 2 Gene Modified Neuroblastoma Tumor Cells No drug interventions treatment 1 / 2 active_not_recruiting NCT00084422
N2001-03: CEP-701 in Treating Young Patients With Recurrent or Refractory High-Risk Neuroblastoma treatment 1 completed NCT00003122
Surgery in Treating Patients With Neuroblastoma No drug interventions treatment 2 unknown_status NCT01869725
Comparative Study of Sensitivity of Ga-DOTATOC PET vs Octreoscan SPECT + CT diagnostic 2 completed NCT00003425
Phase I/II Study of Escalating-Dose Melphalan w/Autologous SCS & Amifostine Cytoprotect treatment 1 / 2 completed NCT00002825
Docetaxel in Treating Children With Recurrent Solid Tumors treatment 2 completed NCT00085930
Blood T-Cells and EBV Specific CTLs Expressing GD-2 Specific Chimeric T Cell Receptors to Neuroblastoma Patients treatment 1 active_not_recruiting NCT00646230
N2004-03: Intravenous Fenretinide in Treating Young Patients With Recurrent or Resistant Neuroblastoma treatment 1 completed NCT02307630
PET Imaging of Solid Tumors Using 124I-Humanized 3F8: A Pilot Study No drug interventions diagnostic Not Available active_not_recruiting NCT00202930
Use of Rituximab in Opsoclonus-Myoclonus in Children With Neuroblastoma treatment 2 terminated NCT01493830
Biomarkers in Tumor Samples From Younger Patients With Neuroblastoma No drug interventions Not Available Not Available completed NCT01553448
Studying Gene Expression in Samples From Younger Patients With Neuroblastoma No drug interventions Not Available Not Available completed NCT02298348
Sorafenib and Cyclophosphamide/Topotecan in Patients With Relapsed and Refractory Neuroblastoma treatment 1 active_not_recruiting NCT00798148
131I-MIBG With Myeloablative Chemotherapy and Autologous Stem Cell Transplantation for the Treatment of High-risk Neuroblastoma treatment 1 / 2 unknown_status NCT00436657
Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin for Children With Peritoneal Cancer treatment 1 completed NCT03236857
A Study of the Safety and Pharmacokinetics of Venetoclax in Pediatric and Young Adult Patients With Relapsed or Refractory Malignancies treatment 1 completed NCT00004157
Interleukin-11 Plus Filgrastim Prior to Peripheral Stem Cell Transplantation in Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, Breast Cancer, or Other Solid Tumors treatment 2 completed NCT00118326
Donor Bone Marrow Transplant in Treating Young Patients With Cancer or a Non-Cancerous Disease treatment 1 / 2 completed NCT01757626
Combination Therapy of Antibody Hu3F8 With Granulocyte- Macrophage Colony Stimulating Factor (GM-CSF) in Patients With Relapsed/Refractory High-Risk Neuroblastoma treatment 1 / 2 active_not_recruiting NCT01095926
Pharmacokinetic Study of Doxorubicin in Children With Cancer treatment 2 completed NCT03686566
Pediatric Solid Tumor Metabolism [A Prospective Study Exploring Metabolism of Solid Tumors in Pediatrics] No drug interventions Not Available Not Available completed NCT00098865
Thalidomide and Temozolomide in Relapsed or Progressive CNS Disease or Neuroblastoma treatment 2 completed NCT01619865
Safety of 68Ga-DOTA-tyr3-Octreotide PET in Diagnosis of Solid Tumors diagnostic 1 / 2 completed NCT00939965
Isotretinoin in Treating Young Patients With High-Risk Neuroblastoma treatment Not Available unknown_status NCT06190574
Diagnostic Efficacy and Prognostic Value of 18F-FDG PET/CT (MR) in Pediatric Solid Blastoma No drug interventions Not Available Not Available completed NCT03541720
18F-Fluorodopamine PET Studies of Neuroblastoma and Pheochromocytoma No drug interventions diagnostic 0 recruiting NCT00918320
Studies of Temozolomide in Combination With Topotecan in Refractory and Relapsed Paediatric Solid Tumours treatment 2 completed NCT00907920
Studying Tumor Samples From Young Patients With Neuroblastoma No drug interventions Not Available Not Available completed NCT02641782
NB2013-HR German (GPOH) / Dutch (DCOG) Trial treatment 2 terminated NCT00336531
Efficacy of Prophylactic Itraconazole in High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation prevention 4 completed NCT00410631
Observation, Combination Chemotherapy, Radiation Therapy, and/or Autologous Stem Cell Transplant in Treating Young Patients With Neuroblastoma treatment 3 unknown_status NCT00931931
HSV1716 in Patients With Non-Central Nervous System (Non-CNS) Solid Tumors No drug interventions treatment 1 completed NCT04023331
67Cu-SARTATE™ Peptide Receptor Radionuclide Therapy Administered to Pediatric Patients With High-Risk, Relapsed, Refractory Neuroblastoma treatment 1 / 2 recruiting NCT00080873
Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell Transplantation No drug interventions supportive_care Not Available completed NCT01492673
Cyclophosphamide, Topotecan, and Bevacizumab (CTB) in Patients With Relapsed/Refractory Ewing's Sarcoma and Neuroblastoma treatment 2 completed NCT00020527
Caspofungin Acetate in Treating Children With Fever and Neutropenia supportive_care Not Available completed NCT05303727
Allogeneic Hematopoietic Stem Cell Transplantation for 4/M Neuroblastoma treatment 2 not_yet_recruiting NCT00450827
Iodine I 131 Monoclonal Antibody 3F8 and Bevacizumab in Treating Patients With Relapsed or Refractory Neuroblastoma treatment 1 completed NCT01747876
Study of Safety and Efficacy in Patients With Malignant Rhabdoid Tumors (MRT) and Neuroblastoma treatment 1 terminated NCT00716976
Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy supportive_care 3 completed NCT00416676
Combination Chemotherapy and Surgery With or Without Radiation Therapy in Treating Patients With Stage 2 or Stage 3 Neuroblastoma treatment 3 unknown_status NCT00911560
Bivalent Vaccine With Escalating Doses of the Immunological Adjuvant OPT-821, in Combination With Oral β-glucan for High-Risk Neuroblastoma treatment 1 / 2 active_not_recruiting NCT02100891
Phase 2 STIR Trial: Haploidentical Transplant and Donor Natural Killer Cells for Solid Tumors treatment 2 completed NCT03478462
Dose Escalation Study of CLR 131 in Children, Adolescents, and Young Adults With Relapsed or Refractory Malignant Tumors Including But Not Limited to Neuroblastoma, Rhabdomyosarcoma, Ewings Sarcoma, and Osteosarcoma treatment 1 active_not_recruiting NCT02441062
Impact of Ga-68 DOTATOC PET-CT Imaging in Management of Neuroendocrine Tumors diagnostic 2 completed NCT03709680
Study Of Palbociclib Combined With Chemotherapy In Pediatric Patients With Recurrent/Refractory Solid Tumors treatment 1 / 2 active_not_recruiting NCT05192980
SIOPEN BIOPORTAL, An International Registry Linked to a Virtual Biobank for Patients With Peripheral Neuroblastic Tumours No drug interventions other Not Available recruiting NCT00006480
Biological Therapy and Gene Therapy in Treating Children With Recurrent or Refractory Neuroblastoma treatment 1 completed NCT01222780
To Evaluate the Safety, Activity and Pharmacokinetics of Marqibo in Children and Adolescents With Refractory Cancer treatment 1 completed NCT03042429
Combination Chemotherapy Followed by Stem Cell Transplant in High-risk Neuroblastoma Patients treatment 3 completed NCT01048892
Seneca Valley Virus-001 and Cyclophosphamide in Treating Young Patients With Relapsed or Refractory Neuroblastoma, Rhabdomyosarcoma, or Rare Tumors With Neuroendocrine Features treatment 1 completed NCT01576692
Combination Chemotherapy, Monoclonal Antibody, and Natural Killer Cells in Treating Young Patients With Recurrent or Refractory Neuroblastoma treatment 1 completed NCT02679144
Neuroblastoma Maintenance Therapy Trial prevention 2 recruiting NCT03015844
A Compassionate Use/Expanded Access Protocol Using 131I-MIBG Therapy for Patients With Refractory Neuroblastoma and Metastatic Pheochromocytoma Not Available Not Available available NCT00002740
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation Followed by Surgery and/or Radiation Therapy in Treating Young Patients With Advanced Neuroblastoma treatment 1 completed NCT00303940
Talabostat Combined With Temozolomide or Carboplatin in Treating Young Patients With Relapsed or Refractory Brain Tumors or Other Solid Tumors treatment 1 completed NCT03581240
An Intermediate Expanded Use Trial of DFMO Not Available Not Available available NCT00392340
Topotecan, Vincristine, and Doxorubicin in Treating Young Patients With Refractory Stage 4 Neuroblastoma treatment 2 unknown_status NCT00947167
A Phase II Study of Pertuzumab and Erlotinib for Metastatic or Unresectable Neuroendocrine Tumors treatment 2 terminated NCT02176967
Response and Biology-Based Risk Factor-Guided Therapy in Treating Younger Patients With Non-high Risk Neuroblastoma treatment 3 active_not_recruiting NCT03332667
MIBG With Dinutuximab +/- Vorinostat treatment 1 active_not_recruiting NCT01638572
Exploring the Possibility to Use Glycosyltransferase as a Prognosis Marker of Neuroblastoma No drug interventions Not Available Not Available completed NCT00428272
HGS-ETR2 to Treat Children With Solid Tumors treatment 1 terminated NCT03721068
Study of CAR T-Cells Targeting the GD2 With IL-15+iCaspase9 for Relapsed/Refractory Neuroblastoma or Relapsed/Refractory Osteosarcoma treatment 1 recruiting NCT02868268
Neuroblastoma Precision Trial No drug interventions Not Available Not Available active_not_recruiting NCT00900068
Blood Samples From Patients on a Clinical Trial to CINV During HSCT No drug interventions Not Available Not Available terminated NCT00017368
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Neuroblastoma treatment 2 completed NCT01807468
Haploidentical Stem Cell Transplantation and NK Cell Therapy in Patients With High-risk Solid Tumors No drug interventions treatment 2 unknown_status NCT03209869
Treatment of Relapsed or Refractory Neuroblastoma and Osteosarcoma With Expanded Haploidentical NK Cells and Hu14.18-IL2 treatment 1 withdrawn NCT02130869
A Pilot Study of Immunotherapy Including Haploidentical NK Cell Infusion Following CD133+ Positively-Selected Autologous Hematopoietic Stem Cells in Children With High Risk Solid Tumors or Lymphomas treatment 1 completed NCT00003846
Radiation Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Primitive Neuroectodermal Tumors treatment 2 completed NCT00996710
Genomic Structural Variation in Cancer Susceptibility No drug interventions Not Available Not Available active_not_recruiting NCT04706910
18F-DOPA II - PET Imaging Optimization diagnostic 3 recruiting NCT00877110
Anti-GD2 3F8 Antibody and Allogeneic Natural Killer Cells for High-Risk Neuroblastoma treatment 1 completed NCT06502210
Identification of New Gene Spliceosomes in Neuroblastoma No drug interventions Not Available Not Available recruiting NCT00670410
Autologous Transplant Followed by Allogeneic Transplant for High Risk Neuroblastoma treatment 1 terminated NCT00084695
Umbilical Cord Blood for Stem Cell Transplantation in Treating Young Patients With Malignant or Nonmalignant Diseases treatment 2 unknown_status NCT01192555
Allogeneic Tumor Cell Vaccination With Oral Metronomic Cytoxan in Patients With High-Risk Neuroblastoma treatment 1 / 2 active_not_recruiting NCT01114555
Bevacizumab, Irinotecan and Temozolomide for Relapsed or Refractory Neuroblastoma treatment 2 completed NCT00898755
Collecting and Storing Tissue From Young Patients With Cancer No drug interventions Not Available Not Available active_not_recruiting NCT00005955
Temozolomide Followed by Radiation Therapy in Treating Children With Newly Diagnosed Malignant CNS Tumors treatment 2 completed NCT00287950
Combination Chemotherapy, Surgery, and Radiation Therapy in Treating Infants With Neuroblastoma treatment Not Available unknown_status NCT02457650
T Cell Receptor-transduced T Cells Targeting NY-ESO-1 for Treatment of Patients With NY-ESO-1- Expressing Malignancies treatment 1 unknown_status NCT00049023
Radiolabeled Octreotide in Treating Children With Advanced or Refractory Solid Tumors No drug interventions treatment 1 completed NCT00003408
Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Cancer treatment 2 completed NCT00582608
Tumor Detection Using Iodine-131-Labeled Monoclonal Antibody 8H9 No drug interventions diagnostic Not Available terminated NCT01802138
A Pilot Study of Activated T Cell Therapy for Refractory/Relapsed Neuroblastoma No drug interventions treatment Not Available completed NCT01319838
Aflac ST1001 Prolonged Isotretinoin treatment 1 withdrawn NCT02508038
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors treatment 1 recruiting NCT00002543
Gallium Nitrate in Treating Children With Brain Tumor, Neuroblastoma, Rhabdomyosarcoma, Non-Hodgkin's Lymphoma, or Refractory Solid Tumors treatment 1 completed NCT04637503
4SCAR-T Therapy Targeting GD2, PSMA and CD276 for Treating Neuroblastoma No drug interventions treatment 1 / 2 unknown_status NCT05400603
Allogeneic Expanded Gamma Delta T Cells With GD2 Chemoimmunotherapy in Relapsed /Refractory Neuroblastoma or Refractory/ Relapsed Osteosarcoma treatment 1 recruiting NCT01526603
High Dose Chemotherapy and Autologous Transplant for Neuroblastoma other Not Available completed NCT03503864
Phase II Study of Combined Chemotherapy With Arsenic Trioxide in Stage 4/M Neuroblastoma treatment 2 recruiting NCT02030964
N2012-01: Phase 1 Study of Difluoromethylornithine (DFMO) and Celecoxib With Cyclophosphamide/Topotecan treatment 1 active_not_recruiting NCT04864821
Clinical Study of CD276 Targeted Autologous Chimeric Antigen Receptor T Cell Infusion in Patients With CD276 Positive Advanced Solid Tumor No drug interventions treatment 0 unknown_status NCT04897321
B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR) treatment 1 recruiting NCT02311621
Engineered Neuroblastoma Cellular Immunotherapy (ENCIT)-01 No drug interventions treatment 1 active_not_recruiting NCT03275402
131I-omburtamab Radioimmunotherapy for Neuroblastoma Central Nervous System/Leptomeningeal Metastases treatment 2 / 3 terminated NCT00002802
Therapy Based on Stage of Disease and Risk Assessment in Treating Children With Neuroblastoma treatment 3 completed NCT00006102
Rebeccamycin Analogue in Treating Children With Solid Tumors or Non-Hodgkin's Lymphoma treatment 2 completed NCT01404702
Pilot Study of Zoledronic Acid and Interleukin-2 for Refractory Pediatric Neuroblastoma treatment 1 terminated NCT02444884
MLN8237 to Treat Children With Relapsed/Refractory Solid Tumors treatment 1 completed NCT01183884
3F8/GM-CSF Immunotherapy Plus 13-Cis-Retinoic Acid for Consolidation of Second or Greater Remission of High-Risk Neuroblastoma treatment 2 terminated NCT01169584
Safety Study of Recombinant Vaccinia Virus to Treat Refractory Solid Tumors in Pediatric Patients treatment 1 completed NCT00003484
Radiolabeled Monoclonal Antibody Therapy After Radiation Therapy in Treating Patients With Primary Brain Tumors treatment 1 completed NCT00695279
Long Term Follow Up Of Patients Who Have Received Gene Therapy Or Gene Marked Products No drug interventions Not Available Not Available recruiting NCT01355679
Molecular Guided Therapy for Refractory or Recurrent Neuroblastoma No drug interventions diagnostic Not Available completed NCT06000787
MCT for the Harvard/UCSF ROBIN Center No drug interventions basic_science Not Available recruiting NCT03013387
Dosimetry Guided PRRT With 90Y-DOTATOC treatment 2 withdrawn NCT02933333
G-CSF Alone or Combination With GM-CSF on Prevention and Treatment of Infection in Children With Malignant Tumor treatment 4 unknown_status NCT01520233
Gene Expression in Predicting Outcome in Samples From Patients With High-Risk Neuroblastoma No drug interventions Not Available Not Available completed NCT00407433
Clinical Studies of Gemcitabine-Oxaliplatin treatment 2 completed NCT02557854
HIFU Hyperthermia With Liposomal Doxorubicin (DOXIL) for Relapsed or Refractory Pediatric and Young Adult Solid Tumors treatment 1 withdrawn NCT01598454
Use of Racotumomab in Patients With Pediatric Tumors Expressing N-glycolylated Gangliosides treatment 1 completed NCT00923351
Therapy to Treat Ewing's Sarcoma, Rhabdomyosarcoma or Neuroblastoma No drug interventions treatment 1 / 2 completed NCT03966651
A Clinical Study Evaluating the Safety of Peptide Receptor Radionuclide Therapy (PRRT) With 177Lu-DOTA0-Tyr3-Octreotate in Children With Refractory or Recurrent Neuroblastoma Expressing Somatostatin Receptors. treatment 1 recruiting NCT01625351
A Study of CD45RA+ Depleted Haploidentical Stem Cell Transplantation in Children With Relapsed or Refractory Solid Tumors and Lymphomas treatment 1 completed NCT00417053
Combination Chemotherapy in Treating Infants With Newly Diagnosed Neuroblastoma Who Are Undergoing Surgery With or Without Autologous Bone Marrow or Peripheral Stem Cell Transplant treatment 3 unknown_status NCT00509353
N2004-06: Irinotecan and Vincristine With 131I-MIBG Therapy for Resistant/Relapsed High-Risk Neuroblastoma treatment 1 completed NCT04385277
Treatment With Dinutuximab, Sargramostim (GM-CSF), and Isotretinoin in Combination With Irinotecan and Temozolomide After Intensive Therapy for People With High-Risk Neuroblastoma (NBL) treatment 2 active_not_recruiting NCT06485947
Study Combining Dinutuximab Beta With Two Chemotherapy Regimens in Neuroblastoma treatment 1 not_yet_recruiting NCT00840047
Methionine PET/CT Studies In Patients With Cancer diagnostic 2 recruiting NCT00089245
Radiolabeled MAB Therapy in Patients With Refractory, Recurrent, or Advanced CNS or Leptomeningeal Cancer treatment 1 terminated NCT01853345
iCAT for Recurrent/Refractory/HR Solid Tumors No drug interventions Not Available Not Available completed NCT00782145
A Web-Based Stem Cell Transplant Support System or Standard Care in Young Patients Undergoing Stem Cell Transplant and Their Families No drug interventions supportive_care 3 completed NCT06335745
PediCARE Health Equity Intervention in High-Risk Neuroblastoma No drug interventions supportive_care Not Available withdrawn NCT01308905
Monitor Response to Treatment in Neuroblastoma Using 3&Apos;-Deoxy-3&Apos;-Fluorothymidine- Positron Emission Tomography (FLT-PET) No drug interventions diagnostic Not Available unknown_status NCT00281905
Combination Chemotherapy With or Without Radiation Therapy in Treating Children With Brain Tumors treatment 2 unknown_status NCT03373097
Anti-GD2 CAR T Cells in Pediatric Patients Affected by High Risk and/or Relapsed/Refractory Neuroblastoma or Other GD2-positive Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT05421897
Rapid Administration Pilot for Infusing Dinutuximab treatment 4 recruiting NCT02245997
Local Control With Reduced-dose Radiotherapy for High-Risk Neuroblastoma No drug interventions treatment Not Available active_not_recruiting NCT00025597
Combination Chemotherapy Followed by Surgery in Treating Infants With Newly Diagnosed Neuroblastoma. treatment 2 completed NCT02998983
Racotumomab in Patients With High-risk Neuroblastoma treatment 2 completed NCT00010283
Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or Colon supportive_care 1 / 2 completed NCT00003461
Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Brain Tumors No drug interventions treatment 1 / 2 completed NCT03583528
DOTATOC PET/CT for Imaging NET Patients No drug interventions Not Available Not Available recruiting NCT03458728
Safety, Tolerability, Efficacy and Pharmacokinetics of Copanlisib in Pediatric Patients treatment 1 / 2 terminated NCT01132911
A Phase I Study of Vorinostat and Bortezomib in Children With Refractory of Recurrent Solid Tumors, Including CNS Tumors and Lymphomas treatment 1 completed NCT00037011
Beta-Glucan and Monoclonal Antibody in Treating Patients With Metastatic Neuroblastoma treatment 1 completed NCT00003093
Combination Chemotherapy in Treating Children With Neuroblastoma treatment 3 completed NCT02693171
Post-Marketing Assessment of Immunogenicity and Safety of Unituxin® in High-Risk Neuroblastoma Patients Not Available Not Available terminated NCT04474678
Quality Improvement Project - "My Logbook! - I Know my Way Around!"; ("Mein Logbuch - Ich Kenne Mich Aus!") No drug interventions treatment Not Available completed NCT00005978
N99-01: Combination Chemotherapy, Radiation Therapy, and Stem Cell Transplantation in Treating Patients With Neuroblastoma treatment 1 completed NCT02559778
Pediatric Precision Laboratory Advanced Neuroblastoma Therapy treatment 2 recruiting NCT04483778
B7H3 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults treatment 1 active_not_recruiting NCT00004188
Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Neuroblastoma treatment 3 completed NCT04040088
An Investigational Scan (68Ga-DOTATATE PET/CT) in Diagnosing Pediatric Metastatic Neuroendocrine Tumors diagnostic 0 recruiting NCT00450307
Monoclonal Antibody 3F8 and GM-CSF in Treating Young Patients With High-Risk, Refractory or Relapsed Neuroblastoma treatment 1 completed NCT03860207
Study of the Safety and Efficacy of Humanized 3F8 Bispecific Antibody (Hu3F8-BsAb) in Patients With Relapsed/Refractory Neuroblastoma, Osteosarcoma and Other Solid Tumor Cancers treatment 1 / 2 terminated NCT00698009
Haploidentical Natural Killer (NK) Cells in Patients With Relapsed or Refractory Neuroblastoma treatment 2 terminated NCT00001509
A Phase II Trial of All-Trans-Retinoic Acid in Combination With Interferon-Alpha 2a in Children With Recurrent Neuroblastoma or Wilms' Tumor treatment 2 completed NCT00187109
Recombinant Human Thrombopoietin in Children Receiving Ifosfamide, Carboplatin, and Etoposide Chemotherapy treatment 1 / 2 completed NCT02337309
SF1126 for Patients With Relapsed or Refractory Neuroblastoma treatment 1 terminated NCT00101309
Vaccine Therapy and Interleukin-2 in Treating Young Patients With Relapsed or Refractory Ewing's Sarcoma or Neuroblastoma treatment 1 unknown_status NCT02431715
18F-FDOPA PET in Neuroendocrine Tumours No drug interventions Not Available Not Available no_longer_available NCT00874315
Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed or Refractory High-Risk NBL. treatment 2 withdrawn NCT01174537
New Castle Disease Virus (NDV) in Glioblastoma Multiforme (GBM), Sarcoma and Neuroblastoma No drug interventions treatment 1 / 2 withdrawn NCT05770037
DETERMINE Trial Treatment Arm 01: Alectinib in Adult, Teenage/Young Adults (TYA) and Paediatric Patients With ALK Positive Cancers treatment 2 / 3 recruiting NCT01822652
3rd Generation GD-2 Chimeric Antigen Receptor and iCaspase Suicide Safety Switch, Neuroblastoma, GRAIN treatment 1 active_not_recruiting NCT00608452
Prevalence+Significance of Paraneoplastic Autoantibodies in Many Cancers No drug interventions Not Available Not Available completed NCT01587300
Neuroblastoma Biology Study No drug interventions Not Available Not Available recruiting NCT01125800
A Phase I Dose Finding and Safety Study of Oral LDE225 in Children and a Phase II Portion to Assess Preliminary Efficacy in Recurrent or Refractory MB treatment 1 / 2 completed NCT01353300
Gene Mutation in Samples From Young Patients With Pleuropulmonary Blastoma Syndrome at Risk for Developing Cancer No drug interventions Not Available Not Available completed NCT05782959
Phase 1 Study of BCD-245 in Subjects With Neuroblastoma No drug interventions treatment 1 recruiting NCT03561259
A Study of Therapeutic Iobenguane (131-I) and Vorinostat for Recurrent or Progressive High-Risk Neuroblastoma Subjects treatment 2 recruiting NCT00416559
Observation of Young Patients With Localized Neuroblastoma Who Have Undergone Surgery Only No drug interventions supportive_care 2 unknown_status NCT00066599
Voriconazole in Preventing Fungal Infections in Children With Neutropenia After Chemotherapy supportive_care 2 completed NCT05701306
APG-115 Alone or in Combination With APG-2575 in Children With Recurrent or Refractory Neuroblastoma or Solid Tumors treatment 1 recruiting NCT00013806
CHP677: I-Metaiodobenzylguanidine (I-MIBG) Therapy for Refractory Neuroblastoma: a Phase II Study No drug interventions treatment 2 unknown_status NCT00186849
Therapy for Children With Advanced Stage High Risk Neuroblastoma treatment 2 completed NCT00003513
Antineoplaston Therapy in Treating Patients With Metastatic, Recurrent, or Refractory Neuroblastoma treatment 2 terminated NCT06013618
Clinical Analysis of Naxitamab (hu3F8) in the Treatment of Pediatric High Risk or Refractory/ Relapsed Neuroblastoma treatment 2 recruiting NCT00293319
131 I-MIBG in Treating Patients With Refractory or Relapsed Neuroblastoma treatment 2 completed NCT02786719
High-Risk Neuroblastoma Chemotherapy Without G-CSF treatment Not Available completed NCT01386619
NK DLI in Patients After Human Leukocyte Antigen (HLA)-Haploidentical Hematopoietic Stem Cell Transplantation (HSCT) treatment 1 / 2 completed NCT06500819
Autologous B7-H3 Chimeric Antigen Receptor T Cells in Relapsed/Refractory Solid Tumors No drug interventions treatment 1 recruiting NCT00003119
Surgery in Treating Children With Neuroblastoma treatment 3 completed NCT00295919
N2004-04: Fenretinide LXS in Treating Patients With Recurrent, Refractory, or Persistent Neuroblastoma treatment 1 completed NCT00003141
Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Infants With Malignant Brain or Spinal Cord Tumors treatment 1 completed NCT01589341
Studying Chromosomes in Samples From Younger Patients With Neuroblastoma No drug interventions Not Available Not Available completed NCT01482741
Understanding Patient Perspectives on the Risks of Ionizing Radiation Used for Medical Imaging No drug interventions Not Available Not Available completed NCT02112617
Phase II Study of Proton Radiation Therapy for Neuroblastoma No drug interventions treatment Not Available recruiting NCT01857934
Therapy for Children With Advanced Stage Neuroblastoma treatment 2 active_not_recruiting NCT01419834
Humanized 3F8 Monoclonal Antibody (Hu3F8) in Patients With High-Risk Neuroblastoma and GD2-Positive Tumors treatment 1 completed NCT00003234
Vinorelbine in Treating Children With Recurrent or Refractory Cancers treatment 2 completed NCT00726934
The Effectiveness of the Neutropenic Diet in Pediatric Oncology Patients No drug interventions supportive_care Not Available completed NCT00503724
Enzastaurin in Treating Young Patients With Refractory Primary CNS Tumors treatment 1 completed NCT01387724
Biomarkers in Blood and Tissue Samples From Patients With Newly Diagnosed Neuroblastoma No drug interventions Not Available Not Available completed NCT00349024
Polyvinylpyrrolidone-Sodium Hyaluronate Gel in Reducing Pain From Oral Mucositis in Young Patients With Cancer supportive_care Not Available unknown_status NCT01704716
High Risk Neuroblastoma Study 1.8 of SIOP-Europe (SIOPEN) treatment 3 recruiting NCT03042416
18F-DOPA PET Imaging: an Evaluation of Biodistribution and Safety No drug interventions diagnostic 3 completed NCT00499616
Combination Chemotherapy and Surgery With or Without Isotretinoin in Treating Young Patients With Neuroblastoma treatment 3 completed NCT00651716
T Cells in Predicting Acute Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplant No drug interventions Not Available Not Available terminated NCT02573896
Immunotherapy of Relapsed Refractory Neuroblastoma With Expanded NK Cells treatment 1 active_not_recruiting NCT03382158
International PPB/DICER1 Registry No drug interventions Not Available Not Available recruiting NCT00082758
hu14.18-Interleukin-2 Fusion Protein in Treating Young Patients With Recurrent or Refractory Neuroblastoma treatment 2 completed NCT00002458
Monoclonal Antibody Therapy in Treating Children With Metastatic Neuroblastoma in Second Remission treatment 2 completed NCT00024258
Arsenic Trioxide in Treating Patients With Advanced Neuroblastoma or Other Childhood Solid Tumors treatment 2 completed NCT00083135
N2000-01: Double Infusion of Iodine I 131 Metaiodobenzylguanidine Followed by Autologous Stem Cell Transplantation treatment 1 completed NCT01601535
Study of MLN8237 in Combination With Irinotecan and Temozolomide treatment 1 / 2 completed NCT06047535
Naxitamab and Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) Combined With Isotretinoin for Maintenance Treatment of Patients With High-Risk Neuroblastoma in First Complete Response. prevention 4 not_yet_recruiting NCT00005835
N99-02: Melphalan and Buthionine Sulfoximine treatment 1 completed NCT00135135
Therapy for Children With Neuroblastoma treatment 2 completed NCT00253435
N2001-02: I-MIBG With Intensive Chemotherapy and Autologous Stem Cell Rescue for High-Risk Neuroblastoma treatment 2 completed NCT02864563
Pan-genome Analysis of Neuroblastoma by Comparative Genomic Hybridization and Correlation With Pathology for the Diagnostic and the Prognostic Classification No drug interventions basic_science Not Available completed NCT02107963
A Phase I Trial of T Cells Expressing an Anti-GD2 Chimeric Antigen Receptor in Children and Young Adults With GD2+ Solid Tumors treatment 1 completed NCT01048086
90Y DOTA/Retinoic Acid for Neuroblastoma and Neuroendocrine Tumor (NET) treatment 2 withdrawn NCT00754286
A Randomized Trial of The Effectiveness of Aromatherapy on Chemotherapy Induced Nausea and Vomiting in Children With Cancer No drug interventions supportive_care Not Available completed NCT00960739
Iodobenzylguanidine Meta-I131 and Topotecan in Young Patients With Refractory or Relapsed Metastatic Neuroblastoma treatment 2 completed NCT01713439
Allogeneic Neuroblastoma Cells for Relapsed/ Refractory Neuroblastoma, CYCHEALL No drug interventions treatment 1 completed NCT00165139
Intensive Chemo-Radiotherapy With Peripheral Blood Progenitor Cell Rescue for Children With Advanced Neuroblastoma and Sarcomas treatment 2 completed NCT00003022
Monoclonal Antibody Therapy in Treating Patients With Leptomeningeal Cancer No drug interventions treatment 1 completed NCT00017225
Chemotherapy and Radiation Therapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Neuroblastoma treatment 2 completed NCT00788125
Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors treatment 1 / 2 terminated NCT01370330
131I-Labeled MIBG for Refractory Neuroblastoma: A Compassionate Use Protocol Not Available Not Available available NCT02100930
Anti-GD2 3F8 Monoclonal Antibody and GM-CSF for High-Risk Neuroblastoma treatment Not Available completed NCT04308330
Vorinostat in Combination With Chemotherapy in Relapsed/Refractory Solid Tumors and CNS Malignancies treatment 1 recruiting NCT00002730
Chemotherapy in Treating Children With Neuroblastoma treatment 1 completed NCT02650648
Humanized Anti-GD2 Antibody Hu3F8 and Allogeneic Natural Killer Cells for High-Risk Neuroblastoma treatment 1 active_not_recruiting NCT00002748
Gene Therapy in Treating Children With Refractory or Recurrent Neuroblastoma treatment 1 completed NCT00410657
Alemtuzumab and Glucocorticoids in Treating Newly Diagnosed Acute Graft-Versus-Host Disease in Patients Who Have Undergone a Donor Stem Cell Transplant supportive_care 2 completed NCT00885326
N2007-02:Bevacizumab,Cyclophosphamide,& Zoledronic Acid in Patients W/ Recurrent or Refractory High-Risk Neuroblastoma treatment 1 completed NCT00152126
Chemotherapy With CD133+ Select Autologous Hematopoietic Stem Cells for Children With Solid Tumors and Lymphomas treatment Not Available completed NCT00003926
Amifostine to Protect From Side Effects of PSCT in Treating Patients With Solid Tumors supportive_care 1 terminated NCT00389766
High-Dose Iodine I 131 Metaiodobenzylguanidine, Topotecan, and Peripheral Stem Cell Transplant in Treating Young Patients With Relapsed Stage 4 Neuroblastoma or Primary Resistant High-Risk Neuroblastoma treatment 2 withdrawn NCT02395666
Preventative Trial of Difluoromethylornithine (DFMO) in High Risk Patients With Neuroblastoma That is in Remission prevention 2 completed NCT00445965
Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer No drug interventions treatment 2 completed NCT00001565
Phase I and Pharmacokinetic Trial of Phenylbutyrate Given as a Continuous Infusion in Pediatric Patients With Refractory Malignancy treatment 1 completed NCT05069220
18F-MFBG PET/CT in the Evaluation of Neural Crest Tumor diagnostic 0 recruiting NCT01483820
Safety and Efficacy Study of TPI-287 in Neuroblastoma and Medulloblastoma treatment 1 / 2 terminated NCT00801931
Double Cord Blood Transplant for Patients With Malignant and Non-malignant Disorders treatment 1 / 2 terminated NCT00276731
Combination Chemotherapy Followed By Surgery With or Without Radiation Therapy in Treating Young Patients With Stage II or Stage III Neuroblastoma treatment 3 unknown_status NCT01407731
Protein Expression in Human Neuroblastoma Tumor Samples No drug interventions Not Available Not Available completed NCT00992173
Efficacy and Safety of Ultratrace™ Iobenguane I 131 in Neuroblastoma treatment 2 withdrawn NCT00003273
Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Brain Tumor treatment 2 withdrawn NCT01288573
A Combined Study in Pediatric Cancer Patients for Dose Ranging and Efficacy/Safety of Plerixafor Plus Standard Regimens for Mobilization Versus Standard Regimens Alone treatment 1 / 2 completed NCT02177773
GA-68 DOTA-TOC of Somatostatin Positive Malignancies diagnostic 1 / 2 terminated NCT03363373
Naxitamab for High-Risk Neuroblastoma Patients With Primary Refractory Disease or Incomplete Response to Salvage Treatment in Bone and/or Bone Marrow treatment 2 recruiting NCT02308527
Activity Study of Bevacizumab With Temozolomide ± Irinotecan for Neuroblastoma in Children treatment 2 active_not_recruiting NCT00405327
A Pilot Study of Tumor Cell Vaccine for High-risk Solid Tumor Patients Following Stem Cell Transplantation No drug interventions treatment 2 completed NCT01169376
Biomarkers in Young Patients With Neuroblastoma No drug interventions Not Available Not Available completed NCT00002560
Monoclonal Antibody Therapy Plus Sargramostin in Treating Patients With Advanced Neuroblastoma treatment 2 completed NCT01075360
The Role of Aromatic Hydrocarbon Receptor in the Tumorigenesis of Neuroblastoma and Its Relationship With MYCN Expression No drug interventions Not Available Not Available completed NCT01119560
Genetic Susceptibility Biomarkers in Children With Neuroblastoma (Also Known as Neuroblastoma Epidemiology in North America [NENA]) No drug interventions Not Available Not Available completed NCT00003191
Fenretinide in Treating Children With Solid Tumors treatment 1 completed NCT01295762
Immunomonitoring of Children With Neuroblastoma No drug interventions screening Not Available unknown_status NCT01241162
Decitabine Followed by a Cancer Antigen Vaccine for Patients With Neuroblastoma and Sarcoma treatment 1 completed NCT00624962
Early Enteral Tube Feedings in Children Receiving Chemo for AML/MDS & High Risk Solid Tumors No drug interventions supportive_care Not Available withdrawn NCT00186862
Gene Modified Allogeneic Neuroblastoma Cells For Treatment of Relapsed/Refractory Neuroblastoma treatment 1 completed NCT03291080
Oral Liquid 13-cis-retinoic Acid (13-CRA) other 1 / 2 completed NCT03517280
Nutritional Status in Neuroblastoma in Sao Paolo, Brazil No drug interventions Not Available Not Available completed NCT00026780
Eligibility Screening for a NCI Pediatric Oncology Branch Research Study No drug interventions Not Available Not Available completed NCT00944580
A Vaccine Study for High Risk Cancers treatment 1 withdrawn NCT01590680
Expanded Access Protocol Using 131I-MIBG No drug interventions Not Available Not Available available NCT01183429
3F8/GM-CSF Immunotherapy Plus 13-Cis-Retinoic Acid for Consolidation of First Remission After Non-Myeloablative Therapy in Patients With High-Risk Neuroblastoma treatment 2 completed NCT02743429
Phase II Study of Monoclonal Antibody ch14.18/CHO Continuous Infusion in Patients With Primary Refractory or Relapsed Neuroblastoma treatment 2 unknown_status NCT04239092
9-ING-41 in Pediatric Patients With Refractory Malignancies. treatment 1 recruiting NCT02558244
Impact of Image-defined Risk Factors on the Outcome of Patients With Neuroblastoma: A Retrospective Study No drug interventions Not Available Not Available recruiting NCT00730444
Expanded Access Protocol for [123I]mIBG for Patients With Known or Suspected Neuroblastoma Not Available Not Available approved_for_marketing NCT01077440
Presence of Donor-Derived DNA in Semen Samples From Cancer Survivors Who Underwent Donor Stem Cell Transplant No drug interventions Not Available Not Available terminated NCT04239040
GVAX Plus Checkpoint Blockade in Neuroblastoma treatment 1 active_not_recruiting NCT00492167
Beta-Glucan and Monoclonal Antibody 3F8 in Treating Patients With Metastatic Neuroblastoma treatment 1 completed NCT01802567
Molecular-Guided Therapy for Relapsed and Refractory Childhood Cancer No drug interventions treatment Not Available completed NCT00813501
Immunologic Diagnostic Blood Test in Predicting Side-Effects in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Other Diseases No drug interventions Not Available Not Available terminated NCT01875601
NK White Blood Cells and Interleukin in Children and Young Adults With Advanced Solid Tumors treatment 1 completed NCT01460901
Study of Donor Derived, Multi-virus-specific, Cytotoxic T-Lymphocytes for Relapsed/Refractory Neuroblastoma No drug interventions treatment 1 completed NCT01358604
Biomarkers in Samples From Young Patients With Neuroblastoma No drug interventions Not Available Not Available completed NCT04017104
Dynamic Whole Body Positron Emission Tomography/Computed Tomography Imaging No drug interventions Not Available Not Available unknown_status NCT01662804
Humanized 3F8 Monoclonal Antibody (Hu3F8) When Combined With Interleukin-2 in Patients With High-Risk Neuroblastoma and GD2-positive Solid Tumors treatment 1 completed NCT00040872
Multiple Therapies in Treating Patients With Advanced Neuroblastoma treatment 2 completed NCT01704872
ch14.18/CHO Bridging Study treatment 1 completed NCT00867568
TPI 287 in Patients With Refractory or Recurrent Neuroblastoma or Medulloblastoma treatment 1 completed NCT00588068
Molecular Characterization of Neuroblastic Tumor: Correlation With Clinical Outcome No drug interventions Not Available Not Available recruiting NCT03050268
Familial Investigations of Childhood Cancer Predisposition No drug interventions Not Available Not Available recruiting NCT00533169
ZD6474 Alone and in Combination With Retinoic Acid in Pediatric Neuroblastoma treatment 1 terminated NCT01868269
Opsoclonus Myoclonus Syndrome/Dancing Eye Syndrome (OMS/DES) in Children With and Without Neuroblastoma (NBpos and NBneg)Opsoclonus Myoclonus Syndrome/Dancing Eye Syndrome (OMS/DES) in Children With and Without Neuroblastoma (NBpos and NBneg) treatment 3 active_not_recruiting NCT00602446
Deferasirox in Treating Patients With Iron Overload After Undergoing a Donor Stem Cell Transplant supportive_care 2 terminated NCT03273712
Dosimetry-Guided, Peptide Receptor Radiotherapy (PRRT) With 90Y-DOTA- tyr3-Octreotide (90Y-DOTATOC) treatment 2 completed NCT00126412
Meta-Iodobenzylguanidine (123I mIBG) Scintigraphy in Patients Being Evaluated for Phaeochromocytoma or Neuroblastoma diagnostic 3 completed NCT00036712
Light-Emitting Diode Therapy in Preventing Mucositis in Children Receiving Chemotherapy With or Without Radiation Therapy Before Bone Marrow Transplantation No drug interventions supportive_care 2 unknown_status NCT06182410
Defibrotide Prophylaxis of Transplant Associated-Thrombotic Microangiopathy for Neuroblastoma supportive_care 2 withdrawn NCT00025610
Combination Chemotherapy in Treating Infants With Newly Diagnosed Neuroblastoma treatment 2 completed NCT00004110
Monoclonal Antibody Therapy Plus Etoposide in Treating Patients With Neuroblastoma treatment 2 completed NCT05890781
Engineering Immune Organoids to Study Pediatric Cancer No drug interventions other Not Available recruiting NCT03618381
EGFR806 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults No drug interventions treatment 1 recruiting NCT05755295
Horse Therapy for Children, Adolescents and Young Adults in Remission From Medulloblastoma No drug interventions supportive_care Not Available recruiting NCT01986595
A Pilot Study on ALK Gene Mutations in Neuroblastoma No drug interventions Not Available Not Available unknown_status NCT00365755
Combination Chemotherapy in Treating Young Patients Who Are Undergoing Surgery and an Autologous Bone Marrow Transplant for Disseminated Neuroblastoma treatment 3 completed NCT00062855
Using Gene Modified Neuroblastoma Cells for the Treatment of Relapsed/Refractory Neuroblastoma No drug interventions treatment 1 completed NCT05642455
SPEARHEAD-3 Pediatric Study No drug interventions treatment 1 / 2 recruiting NCT00923650
Informed Consent in Pediatric Cancer Trials No drug interventions Not Available Not Available completed NCT00003750
Biological Therapy in Treating Children With Refractory or Recurrent Neuroblastoma or Other Tumors treatment 1 completed NCT01156350
Haplo-identical Hematopoietic Stem Cell Transplantation Following Reduced-intensity Conditioning in Children With Neuroblastoma treatment 2 unknown_status NCT00020150
Temozolomide and O6-benzylguanine in Treating Children With Solid Tumors treatment 1 completed NCT01019850
N2007-03: Vorinostat and 131-I MIBG in Treating Patients With Resistant or Relapsed Neuroblastoma treatment 1 completed NCT05179850
Computer Aided Diagnostic Tool on Computed Tomography Images for Diagnosis of Retroperitoneal Tumor in Children No drug interventions Not Available Not Available unknown_status NCT01204450
Temsirolimus and Valproic Acid in Treating Young Patients With Relapsed Neuroblastoma, Bone Sarcoma, or Soft Tissue Sarcoma treatment 1 terminated NCT05245123
Psychosocial Situation of Children With Rare Solid Abdominal Tumors and Their Families No drug interventions Not Available Not Available completed NCT00025623
Combination Chemotherapy Followed by Surgery in Treating Infants With Newly Diagnosed Neuroblastoma treatment 2 completed NCT01130623
A Phase I Study of Pazopanib as a Single Agent for Children With Refractory Solid Tumors treatment 1 withdrawn NCT00003023
Monoclonal Antibody A1G4 Plus BCG in Treating Patients With Cancer treatment 1 completed NCT00030108
Ixabepilone in Treating Young Patients With Solid Tumors or Leukemia That Haven't Responded to Therapy treatment 1 completed NCT01505608
Randomized Efficacy Study of TPI 287 to Treat Primary Refractory or Early Relapsed Neuroblastoma treatment 1 / 2 terminated NCT00003743
Interleukin-2 in Treating Children With Stage IV Neuroblastoma Who Have Received Induction Therapy and Peripheral Stem Cell Transplantation treatment 2 unknown_status NCT02159443
Pretreatment Anti-Therapeutic Antibodies (PATA) in Patients Treated With hu14.18K322A Antibody No drug interventions Not Available Not Available completed NCT04301843
Eflornithine (DFMO) and Etoposide for Relapsed/Refractory Neuroblastoma treatment 2 recruiting NCT02390843
Simvastatin With Topotecan and Cyclophosphamide in Relapsed and/or Refractory Pediatric Solid and CNS Tumors treatment 1 completed NCT02630043
Trial of Tolcapone With Oxaliplatin for Neuroblastoma treatment 1 terminated NCT01586260
Preventative Trial of DFMO in Patients With High Risk Neuroblastoma in Remission prevention 2 active_not_recruiting NCT02441088
Theranostics: 68GaDOTATOC and 90YDOTATOC treatment 2 active_not_recruiting